« Previous
Next »
Titles
- Medicare Part D2
- Medicare beneficiaries' out-of-pocket spending for health care2
- A comparison of brand-name drug prices among selected federal programs1
- An illustrative analysis of Medicare Options Compare: what's there and what's not1
- Applying a premium cap in Medicare Part B and Part D1
- Capping Medicare beneficiary Part D spending at $2,000: who would it help and how much?1
- Catastrophic coverage in the Medicare Part D drug benefit: which beneficiaries need it and how much are they spending?1
- Closing the "doughnut hole" has helped protect millions of Medicare beneficiaries from high drug costs1
- Cost savings1
- Coverage and payment for prescription drugs under Medicare Part B: a complex patchwork1
- Do states adjust Medicaid enrollment in response to capitation rates?: evidence from the Medicare Part D clawback1
- Does Medicare Part D protect the elderly from financial risk?1
- Drug price increases that exceed inflation are costing Medicare Part D billions1
- Federal mandatory spending for means-tested programs, 2008 to 20281
- High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemia1
- High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases1
- How much does out-of-pocket medical spending eat away at retirement income?1
- How will the Medicare Part D benefit change under current law and leading proposals?1
- Impact of Medicare Advantage prescription drug plan star ratings on enrollment before and after implementation of quality-related bonus payments in 20121
- Increases in reimbursement for brand-name drugs in Part D1